Annual D&A
$17.32 M
+$4.41 M+34.17%
31 December 2023
Summary:
REGENXBIO annual depreciation & amortization is currently $17.32 million, with the most recent change of +$4.41 million (+34.17%) on 31 December 2023. During the last 3 years, it has risen by +$8.91 million (+106.02%). RGNX annual D&A is now at all-time high.RGNX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$3.96 M
-$90.00 K-2.22%
30 September 2024
Summary:
REGENXBIO quarterly depreciation & amortization is currently $3.96 million, with the most recent change of -$90.00 thousand (-2.22%) on 30 September 2024. Over the past year, it has dropped by -$411.00 thousand (-9.40%). RGNX quarterly D&A is now -10.69% below its all-time high of $4.43 million, reached on 30 June 2023.RGNX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$16.53 M
-$411.00 K-2.43%
30 September 2024
Summary:
REGENXBIO TTM depreciation & amortization is currently $16.53 million, with the most recent change of -$411.00 thousand (-2.43%) on 30 September 2024. Over the past year, it has dropped by -$584.00 thousand (-3.41%). RGNX TTM D&A is now -4.59% below its all-time high of $17.32 million, reached on 31 March 2024.RGNX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.2% | -9.4% | -3.4% |
| 3 y3 years | +106.0% | +40.1% | +82.4% |
| 5 y5 years | +335.0% | +112.3% | +152.7% |
RGNX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +106.0% | -10.7% | +52.9% | -4.6% | +82.4% |
| 5 y | 5 years | at high | +335.0% | -10.7% | +112.3% | -4.6% | +152.7% |
| alltime | all time | at high | -10.7% | -4.6% |
REGENXBIO Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.96 M(-2.2%) | $16.53 M(-2.4%) |
| June 2024 | - | $4.05 M(-3.1%) | $16.94 M(-2.2%) |
| Mar 2024 | - | $4.18 M(-3.6%) | $17.32 M(+0.0%) |
| Dec 2023 | $17.32 M(+34.2%) | $4.33 M(-0.8%) | $17.32 M(+1.2%) |
| Sept 2023 | - | $4.37 M(-1.4%) | $17.11 M(+5.1%) |
| June 2023 | - | $4.43 M(+6.2%) | $16.29 M(+12.4%) |
| Mar 2023 | - | $4.18 M(+1.3%) | $14.50 M(+12.3%) |
| Dec 2022 | $12.91 M(+35.0%) | $4.13 M(+16.3%) | $12.91 M(+13.3%) |
| Sept 2022 | - | $3.55 M(+34.3%) | $11.39 M(+6.8%) |
| June 2022 | - | $2.64 M(+2.0%) | $10.67 M(+4.3%) |
| Mar 2022 | - | $2.59 M(-0.6%) | $10.23 M(+6.9%) |
| Dec 2021 | $9.56 M(+13.8%) | $2.61 M(-7.9%) | $9.56 M(+5.5%) |
| Sept 2021 | - | $2.83 M(+28.5%) | $9.06 M(+7.8%) |
| June 2021 | - | $2.20 M(+14.1%) | $8.41 M(+0.8%) |
| Mar 2021 | - | $1.93 M(-8.4%) | $8.34 M(-0.8%) |
| Dec 2020 | $8.41 M(+17.5%) | $2.10 M(-3.3%) | $8.41 M(+2.2%) |
| Sept 2020 | - | $2.18 M(+2.1%) | $8.22 M(+3.9%) |
| June 2020 | - | $2.13 M(+6.9%) | $7.92 M(+5.1%) |
| Mar 2020 | - | $1.99 M(+3.7%) | $7.53 M(+5.3%) |
| Dec 2019 | $7.15 M | $1.92 M(+3.1%) | $7.15 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $1.87 M(+6.7%) | $6.54 M(+16.5%) |
| June 2019 | - | $1.75 M(+8.4%) | $5.62 M(+17.9%) |
| Mar 2019 | - | $1.61 M(+23.1%) | $4.76 M(+19.6%) |
| Dec 2018 | $3.98 M(+48.3%) | $1.31 M(+39.3%) | $3.98 M(+17.3%) |
| Sept 2018 | - | $941.00 K(+5.0%) | $3.39 M(+7.4%) |
| June 2018 | - | $896.00 K(+7.4%) | $3.16 M(+6.5%) |
| Mar 2018 | - | $834.00 K(+15.4%) | $2.97 M(+10.4%) |
| Dec 2017 | $2.69 M(+393.8%) | $723.00 K(+2.4%) | $2.69 M(+19.8%) |
| Sept 2017 | - | $706.00 K(+0.4%) | $2.24 M(+32.2%) |
| June 2017 | - | $703.00 K(+26.9%) | $1.70 M(+61.6%) |
| Mar 2017 | - | $554.00 K(+97.9%) | $1.05 M(+93.0%) |
| Dec 2016 | $544.00 K(+580.0%) | $280.00 K(+75.0%) | $544.00 K(+80.7%) |
| Sept 2016 | - | $160.00 K(+185.7%) | $301.00 K(+78.1%) |
| June 2016 | - | $56.00 K(+16.7%) | $169.00 K(+32.0%) |
| Mar 2016 | - | $48.00 K(+29.7%) | $128.00 K(+60.0%) |
| Dec 2015 | $80.00 K(>+9900.0%) | $37.00 K(+32.1%) | $80.00 K(+86.0%) |
| Sept 2015 | - | $28.00 K(+86.7%) | $43.00 K(+186.7%) |
| June 2015 | - | $15.00 K(>+9900.0%) | $15.00 K(>+9900.0%) |
| Mar 2015 | - | $0.00 | $0.00 |
| Dec 2014 | $0.00 | - | - |
FAQ
- What is REGENXBIO annual depreciation & amortization?
- What is the all time high annual D&A for REGENXBIO?
- What is REGENXBIO annual D&A year-on-year change?
- What is REGENXBIO quarterly depreciation & amortization?
- What is the all time high quarterly D&A for REGENXBIO?
- What is REGENXBIO quarterly D&A year-on-year change?
- What is REGENXBIO TTM depreciation & amortization?
- What is the all time high TTM D&A for REGENXBIO?
- What is REGENXBIO TTM D&A year-on-year change?
What is REGENXBIO annual depreciation & amortization?
The current annual D&A of RGNX is $17.32 M
What is the all time high annual D&A for REGENXBIO?
REGENXBIO all-time high annual depreciation & amortization is $17.32 M
What is REGENXBIO annual D&A year-on-year change?
Over the past year, RGNX annual depreciation & amortization has changed by +$4.41 M (+34.17%)
What is REGENXBIO quarterly depreciation & amortization?
The current quarterly D&A of RGNX is $3.96 M
What is the all time high quarterly D&A for REGENXBIO?
REGENXBIO all-time high quarterly depreciation & amortization is $4.43 M
What is REGENXBIO quarterly D&A year-on-year change?
Over the past year, RGNX quarterly depreciation & amortization has changed by -$411.00 K (-9.40%)
What is REGENXBIO TTM depreciation & amortization?
The current TTM D&A of RGNX is $16.53 M
What is the all time high TTM D&A for REGENXBIO?
REGENXBIO all-time high TTM depreciation & amortization is $17.32 M
What is REGENXBIO TTM D&A year-on-year change?
Over the past year, RGNX TTM depreciation & amortization has changed by -$584.00 K (-3.41%)